middle.news
Telix Pharmaceuticals Bolsters Pipeline with $73M ImaginAb Acquisition
8:31am on Friday 31st of January, 2025 AEDT
•
Biotechnology
Read Story
Telix Pharmaceuticals Bolsters Pipeline with $73M ImaginAb Acquisition
8:31am on Friday 31st of January, 2025 AEDT
Key Points
Acquisition valued at US$45 million upfront, with potential US$185 million in milestones
Adds pipeline candidates targeting DLL3 and integrin avß6 cancer markers
Includes a cutting-edge research facility in Los Angeles and expert discovery team
Enhances Telix’s radiopharmaceutical and protein engineering capabilities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Telix Pharmaceuticals (ASX:TLX)
OPEN ARTICLE